Anika Therapeutics Inc. (ANIK)

15.02

-0.01 (-0.07%)

At close: Apr 01, 2025, 3:59 PM

15.03

0.10%

After-hours: Apr 01, 2025, 04:20 PM EDT

Anika Therapeutics Cash Flow Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-56.38M	-82.67M	-14.86M	4.13M	-23.98M
Depreciation & Amortization	8.12M	14.22M	14.49M	14.32M	13.46M
Stock-Based Compensation	13.13M	15.24M	14.31M	11.09M	5.39M
Other Working Capital	n/a	589K	-1.28M	-783K	-5.96M
Other Non-Cash Items	40.28M	69.87M	7.56M	-4.66M	35.2M
Deferred Income Tax	260K	-6.33M	-5.27M	-1.77M	-3.54M
Change in Working Capital	n/a	-12.12M	-11.82M	-14.72M	-13.46M
Operating Cash Flow	5.4M	-1.79M	4.41M	8.4M	13.06M
Capital Expenditures	-7.73M	-5.43M	-7.49M	-5.14M	-1.63M
Acquisitions	n/a	n/a	n/a	-476K	-94.6M
Purchase of Investments	n/a	n/a	n/a	-2.02M	-20.04M
Sales Maturities Of Investments	n/a	n/a	n/a	2.5M	45M
Other Investing Acitivies	-600K	n/a	-7.49M	2.02M	24.96M
Investing Cash Flow	-8.33M	-5.43M	-7.49M	-3.12M	-71.26M
Debt Repayment	n/a	n/a	-284K	-201K	-558K
Common Stock Repurchased	-10.91M	-5M	-934K	-486K	-262K
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.81M	-1.32M	-4.57M	-6.58M	-3.22M
Financial Cash Flow	-12.73M	-6.32M	-4.85M	-6.78M	-3.77M
Net Cash Flow	-15.71M	-13.46M	-8.06M	-1.43M	-61.65M
Free Cash Flow	-2.33M	-7.21M	-3.08M	3.25M	11.44M